Recent news on Humira

New Analysis Of Data Shows Treatment With Abbott's HUMIRA ...  -  25 May 2007
Medical News Today (press release),Data from the Phase III, pivotal study, called CHARM, were evaluated to assess the effect of ongoing treatment with HUMIRA on the risk of hospitalisation.

Abbott seeks US and EU approvals for Humira as a treatment for ...  -  May 9, 2007
News-Medical.net,Additional data will be submitted from an ongoing open label extension study evaluating the long-term efficacy and safety of HUMIRA.

Abbott Laboratories' Humira Will Replace Centocor's Remicade as ...  -  May 9, 2007
PR Newswire (press release),According to the new report entitled Humira Emerges as the Leading Therapy: A Crohn's Disease Study, Humira outperforms Remicade in efficacy, safety,

Abbott seeks Health Canada approval of HUMIRA(R) for psoriasis  -  May 7, 2007
CNW Telbec (Communiqués de presse),If approved, HUMIRA would offer a new, convenient treatment option to Canadians affected by moderate to severe psoriasis, a chronic auto- immune disease

Abbott Seeks US and EU Regulatory Approvals for HUMIRA(R ...  -  May 7, 2007
PR Newswire (press release),This filing marks the first pediatric indication sought for HUMIRA. JRA, commonly referred to as JIA in the EU, is the most common form of arthritis in

Abbott's HUMIRA® (adalimumab) Receives Positive Opinion From ...  -  Apr 30, 2007
Medical News Today (press release),HUMIRA will be the first self-administered biologic for the treatment of Crohn's disease. This is an important milestone for Abbott, as Crohn′s disease will

Abbott's HUMIRA(R) (Adalimumab) Receives Positive Opinion From ...  -  Apr 28, 2007
Medical News Today (press release),HUMIRA will be the first self-administered biologic for the treatment of Crohn's disease. This is an important milestone for Abbott, as Crohn's disease will

Abbott's Humira recommended for approval by Euro Medicines Agency ...  -  Apr 27, 2007
Forbes,Abbott said the decision is an important milestone for the company, as Crohn's disease will be the fourth approved indication for Humira.

Committee for Medicinal Products for Human Use Post-authorisation ...  -  Apr 27, 2007
PharmaLive.com (press release),Humira is indicated for treatment of severe, active Crohn’s disease, in patients who have not responded despite a full and adequate course of therapy with a

When rest makes pain worse  -  May 15, 2007
Melbourne Herald Sun,He was treated with anti-inflammatories and then with one of the new-generation biologic drugs -- Humira, Remicade and Enbrel -- which are available under

New BioTrends Report Highlights The Growing Use Of Biologics Among ...  -  May 1, 2007
Medical News Today (press release),Among Rheumatologists, the TNF-alpha antagonists (such as Amgen/Wyeth's Enbrel and Abbott's Humira) are expected to maintain the first line biologic

Abbott: Experimental psoriasis drug cleared skin  -  May 4, 2007
Chicago Tribune,Abbott already has asked the US Food and Drug Administration to approve the arthritis treatment Humira, the company's top-selling drug, to be marketed as a

NYU sues drug company over patent  -  26 Apr 2007
NYU Washington Square News,The co-plaintiffs claim that Abbott's top-selling drug, Humira, uses the same technology that was patented in July 2006 for their drug Remicade,

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Genetic Engineering News (press release),...including Abbott's Humira(R), Amgen's Neupogen(R) and Neulasta(R), Genentech's Rituxan(R), Gilead's Emtriva(R), Truvada(R) and Atripla(R), and Celgene's

Royalty Pharma and InNexus Biotechnology Announce Agreement ...  -  26 Apr 2007
Business Wire (press release),...including Abbott’s Humira®, Amgen’s Neupogen® and Neulasta®, Genentech’s Rituxan®, Gilead’s Emtriva®, Truvada® and Atripla®, and Celgene’s Thalomid®.

Abbott Profit Falls; Shares Slip on Humira Concern  -  Apr 18, 2007
Reuters.uk,Although Humira sales soared 46 percent to $571 million, Bank of America analyst Glenn Novarro said performance of Abbott's most important product was

Expenses Hurts Abbott Labs' Net; Humira, Depakote Sales Strong  -  Apr 18, 2007
Wall Street Journal (subscription),Humira sales increased 32% in the US and 62% in the rest of the world. Other top-selling drugs included Depakote, which is used to treat bipolar disorder.

Abbott opens new Humira plant  -  Apr 11, 2007
Waukegan News Sun,To meet the soaring demand for Humira, Abbott Laboratories Tuesday opened a $450 million plant in Puerto Rico to manufacture the rheumatoid arthritis drug

Abbott's Puerto Rico site to make Humira  -  Apr 10, 2007
United Press InternationalThe company said the new facility will support the long-term production of its lead biologic drug, Humira -- a human monoclonal antibody to treat rheumatoid

Abbott Seeks US and EU Regulatory Approval for HUMIRA(R ...  -  Apr 3, 2007
Drug Newswire (press release),Psoriasis affects 125 million people worldwide and is the fifth autoimmune disease targeted for HUMIRA therapy in both the United States and Europe.

Abbott Seeks US and EU Regulatory Approval for HUMIRA(R ...  -  Apr 2, 2007
PipelineReview.com (press release),Two Clinical Trials Demonstrate Promising Results in Psoriasis, the Fifth Autoimmune Disease Submission for HUMIRA. ABBOTT PARK, IL, USA | Apr 2,

Abbott Labs files Humira in the USA and Europe for psoriasis  -  Apr 3, 2007
Pharma Times (subscription),Abbott Laboratories has filed its anti-inflammatory blockbuster Humira with US and European regulators for psoriasis in a bid to get approval for a fifth

Abbott Files for Humira Psoriasis Use  -  Apr 2, 2007
Forbes,Specifically, the applications seek to get Humira approved for moderate to severe chronic plaque psoriasis, a condition where the immune system mistakenly

Abbott eyes Humira for treating psoriasis  -  Apr 3, 2007
Worcester Telegram,Abbott Laboratories said its Humira rheumatoid arthritis drug was successful against symptoms of the skin disease psoriasis in two clinical trials,

Abbott says Humira works on psoriasis  -  Apr 3, 2007
Therapeutics Daily (subscription) (press release),Abbott Laboratories said its Humira arthritis drug was successful against symptoms of the skin disease psoriasis in two clinical trials, and the company is

Abbott files Humira for psoriasis  -  Apr 2, 2007
United Press InternationalABBOTT PARK, Ill., April 2 (UPI) -- Abbott said Monday it filed for approval of Humira as a psoriasis treatment in both the United States and Europe.

Abbott Opens New Biotechnology Manufacturing Facility In Puerto  -  Apr 16, 2007
Pharmaceutical Online (press release),The new facility, Abbott Biotechnology Limited (ABL), received US Food and Drug Administration (FDA) approval in February to commercially produce HUMIRA for

Abbott Files for Approval of Humira for Psoriasis  -  Apr 2, 2007
Reuters.uk,N: Quote, Profile , Research) said on Monday it has filed an application with US and European regulators to market its rheumatoid arthritis drug Humira as a

Abbott seeks US, EU approval to market Humira as treatment for ...  -  Apr 2, 2007
Forbes,Abbott said the submissions are the fifth autoimmune disease targeted for Humira therapy in the US and EU and are based on two double-blind,

Abbott files for approval of Humira for psoriasis  -  Apr 2, 2007
ReutersN: Quote, Profile, Research) said on Monday it has filed an application with US and European regulators to market its rheumatoid arthritis drug Humira as a

Abbott Reports 15.5 Percent Sales Growth in First Quarter  -  Apr 18, 2007
MSN MoneyWorldwide pharmaceutical sales increased 16.6 percent, including US sales growth of 16.8 percent, driven by strong growth in HUMIRA, as well as the first

Abbott files for approval of Humira for psoriasis  -  Apr 2, 2007
Therapeutics Daily (subscription) (press release),Humira is a fully human monoclonal antibody that works by blocking a protein known as tumor necrosis factor alpha, which plays a central role in the body's

Abbott pitches Humira for psoriasis  -  Apr 2, 2007
CNNMoney.comAbbott (down $0.01 to $55.80, Charts) submitted its drug Humira, already approved to treat four diseases, to the Food and Drug Administration and European

Abbott slips, but beats forecasts  -  Apr 19, 2007
Chicago Sun-Times,The company said Humira, a rheumatoid arthritis drug that has landed expanded approvals, generated $571 million in global sales in the first quarter,

Abbott opens biotech facility in Puerto Rico  -  Apr 12, 2007
News-Medical.net,With this state-of-the-art facility, we can supply HUMIRA to the growing number of patients who have come to rely on this breakthrough product."

Top earnings reports from the US and Europe  -  Apr 19, 2007
International Herald Tribune,Sales of Humira rose 46 percent to $571 million. Some analysts estimated that the drug's revenue would be $40 million to $50 million higher after the

Abbott Reports 15.5 Percent Sales Growth in First Quarter  -  Apr 18, 2007
PR Newswire (press release),Double-Digit Sales Growth in Both Pharmaceuticals and Medical Products - - Launched HUMIRA(R) for Crohn's Disease and Submitted for Psoriasis Approval

Analysis: Street lukewarm on Abbott  -  Apr 18, 2007
United Press InternationalAbbott attributed the growth of its pharmaceuticals to the Kos Pharmaceuticals acquisition, a 40-percent increase in Humira sales and increased revenue from

J&J, NYU charge Abbott with infringement  -  Apr 18, 2007
Chicago Sun-Times,Abbott Laboratories has been hit with a lawsuit tied to its top-selling arthritis drug Humira, filed by New York University and Johnson & Johnson subsidiary

Abbott outlook called positive  -  Apr 19, 2007
Worcester Telegram,JP Morgan’s Michael Weinstein said in a note to investors that “the outlook for key business drivers like Humira remains solid.�

Abbott's 1st-quarter profit falls 19 percent but sales, guidance up  -  Apr 18, 2007
North County Times,JP Morgan's Michael Weinstein said in a note to investors that "the outlook for key business drivers like Humira remains solid."

Abbott's 1st-quarter profit falls 19 percent but sales, guidance up  -  Apr 18, 2007
San Diego Union Tribune,JP Morgan's Michael Weinstein said in a note to investors that “the outlook for key business drivers like Humira remains solid.�

Abbott's 1Q profit falls 19 percent but sales, guidance up  -  Apr 18, 2007
International Herald Tribune,Benefiting from continued strong sales of its anti-inflammatory drug Humira, the company exceeded Wall Street estimates for earnings after expenses and also

Abbott Quarterly Earnings Fall on Kos Purchase Costs (Update5)  -  Apr 18, 2007
BloombergSales of Humira jumped 46 percent to $571 million after Abbott won clearance to sell it for a spine condition, psoriatic arthritis and for Crohn's disease,

Abbott reports profit slips, boosts year view  -  Apr 18, 2007
MarketWatchGlobal sales of Abbott's flagship product, the rheumatoid arthritis drug Humira, jumped 46% to $571 million. Abbott's next best-selling drug,

J&J, NYU charge Abbott with infringement; Lake County company says ...  -  Apr 18, 2007
Therapeutics Daily (subscription) (press release),Abbott Laboratories has been hit with a lawsuit tied to its top- selling arthritis drug Humira, filed by New York University and Johnson & Johnson

Abbott Quarterly Earnings Fall on Kos Purchase Costs (Update3)  -  Apr 18, 2007
BloombergSales of Humira, which last year accounted for almost 10 percent of Abbott's revenue, rose to $571 million in the quarter, beating Nalbone's estimate of

Earnings Preview: Abbott Laboratories  -  Apr 16, 2007
Forbes,In late February, Abbott received its fourth FDA-approval for its best-selling anti-inflammation drug Humira, this time to treat moderately to severely

Abbott Laboratories opens new $450 million Puerto Rico plant  -  Apr 11, 2007
Worcester Telegram,Abbott Laboratories yesterday opened a $450 million drug manufacturing plant in Puerto Rico that will take over most of the production of Humira,

Abbott reports 19% decline in net  -  Apr 19, 2007
Chicago Tribune,Sales rose 15.5 percent, to $5.29 billion, driven by improving market share of its blockbuster rheumatoid arthritis drug Humira. On a conference call with

JPMorgan records record $4.79b  -  Apr 19, 2007
Boston Globe,Revenue from the top-selling arthritis drug, Humira, also missed analysts' estimates . Net income fell to $698 million, or 45 cents a share,

Abbott sees dip in Q1 earnings  -  Apr 19, 2007
Pharma Times (subscription),Abbott saw double-digit growth in pharmaceutical sales in the first quarter on strong sales of Humira, but net income dropped 19% to $697.5 million over the

Abbott stock surges on news of medical stent superiority  -  27 Mar 2007
Press-Enterprise (subscription),Weinstein wrote in his report Monday. Pre-tax profit margins for Xience V and Humira are roughly twice those of Abbott's other products, he said.

HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ...  -  Mar 12, 2007
Drug Newswire (press release),HUMIRA is also indicated for reducing the signs and symptoms and inducing clinical remission in these patients if they have also lost response to or are

New hope for those suffering from Crohn–s  -  Mar 20, 2007
Newsday,However, last month the Food and Drug Administration approved Humira, manufactured by Abbott Laboratories, for treatment of Crohn's.

HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ...  -  Feb 28, 2007
PipelineReview.com (press release),Announced today it has received US Food and Drug Administration (FDA) approval to market HUMIRA(R) (adalimumab) as a treatment for reducing the signs and

Abbott's Humira OKd for Crohn's  -  Feb 28, 2007
Chicago Tribune,Abbott Laboratories' blockbuster drug Humira has been approved to treat adult patients with "moderately to severely active Crohn's disease," the Food and

HUMIRA(R) (Adalimumab) Receives FDA Approval For Treatment of ...  -  Feb 27, 2007
PR Newswire (press release),HUMIRA is the First and Only Self-Administered Biologic Treatment for Moderate to Severe Crohn's Disease ABBOTT PARK, Ill., Feb.

FDA OKs Abbott's Humira to treat Crohn's disease  -  Feb 27, 2007
MarketWatchThe FDA said the labeling of Humira includes a boxed warning, the strongest type of label warning, due to serious side effects linked to the drug.

Abbott Hits 52-Week High on Humira OK  -  Feb 28, 2007
Forbes,The Food and Drug Administration approved Humira at midday Tuesday for moderately to severely active Crohn's disease, a chronic condition where inflammation

Abbott’s Humira will treat Crohn’s  -  Feb 28, 2007
Chicago Daily Herald,Abbott Laboratories on Tuesday said it won the much-anticipated federal approval to market its top selling arthritis drug Humira to treat adults with

Humira OK’d to treat Crohn’s  -  Feb 28, 2007
Worcester Telegram,Abbott Laboratories won US approval to market the arthritis drug Humira to treat adults with Crohn’s disease, a bowel disorder that can require surgery.

FDA approves Humira (adalimumab) for Crohn's disease  -  Feb 27, 2007
News-Medical.net,The US Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease,

New Crohn's disease treatment Humira promises to reduce symptoms  -  Feb 28, 2007
News-Medical.net,The Food and Drug Administration (FDA) in the United States has given it's approval for the use of the drug Humira (adalimumab) to treat adults suffering

Biologic Humira Approved for Treatment of Crohn's Disease  -  Feb 28, 2007
Biologic Drug Report,Humira (adalimumab), a biologic response modifier widely used for treatment of adult patients with moderate to severe rheumatoid arthritis, was approved by

Humira Approved for Crohn's Disease  -  Feb 27, 2007
Atlanta Journal Constitution (subscription),Humira works to reduce levels of human tumor necrosis factor (TNF) alpha, a chemical that plays a role in abnormal responses from the body's immune system,

FDA OKs Abbott's Humira to treat Crohn's disease  -  Feb 27, 2007
MarketWatchSAN FRANCISCO (MarketWatch) -- The Food and Drug Administration said Tuesday it has approved Humira to treat adult patients with moderately to severely

Abbott gets OK to promote Humira for Crohn's  -  Feb 27, 2007
Crain's Chicago Business,...(Reuters) — Abbott Laboratories Inc. won US approval to promote its injectable arthritis drug Humira for treating patients with moderate to severe forms of

Humira approved to treat Crohn's disease  -  Mar 2, 2007
Kentucky Lake Times,The UPI reports that the US Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active

FDA OKs Humira for Crohn's Disease  -  Feb 27, 2007
Therapeutics Daily (subscription) (press release),The drug Humira (adalimumab) has been approved to treat adults with moderately to severely active Crohn's disease, the US Food and Drug Administration said

Amgen’s Enbrel drug losing market share  -  Mar 20, 2007
Providence Journal,The following year, the pharmaceutical company Abbott began selling the drug Humira to treat rheumatoid arthritis. It can be injected without visiting a

Global Biotech Drug Market Grows by 17.9 Percent in 2006  -  Mar 23, 2007
Biologic Drug Report,..."Ranked twelfth in size among leading classes, growth in autoimmune agents was fueled by the increased use of anti-TNF agents such as Remicade and Humira

For Treatment of Crohn's Disease  -  Feb 27, 2007
Wall Street Journal (subscription),CHICAGO -- The US Food and Drug Administration said Tuesday it has approved Humira, a drug made by Abbott Laboratories Inc., to treat adult patients with

FDA Approves New Treatment For Crohn’s Disease  -  Mar 1, 2007
WebWire (press release),The Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn’s disease,

FDA Approves New Treatment For Crohn's Disease  -  Feb 28, 2007
eMaxHealth.com,The Food and Drug Administration (FDA) approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease,

FDA approves new treatment for crohn's disease  -  Feb 27, 2007
SpiritIndia,The Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease,

FDA Approves New Treatment For Crohn's Disease  -  Feb 27, 2007
PharmaLive.com (press release),27, 2007-The Food and Drug Administration (FDA) today approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's

FDA Approves New Treatment For Crohn's Disease  -  Feb 28, 2007
DG NewsBETHESDA, MD – February 28, 2007 -- The FDA has approved Humira (adalimumab) to treat adult patients with moderately to severely active Crohn's disease.

Abbott cleared to market Crohn's drug in US  -  Feb 28, 2007
Pharmaceutical Business ReviewAbbott Laboratories has received FDA approval to market Humira as a treatment for reducing the symptoms and inducing clinical remission in adults with

New Drug Helps Treat Crohn's Disease  -  Mar 12, 2007
KNDO/KNDU,The drug is called Humira. The FDA approved it last month. Local Gastroenterologists are now starting to prescribe the drug for patients who have Crohn's

Eisai and Abbott Announce Amendment to Agreement for the Co ...  -  Mar 1, 2007
PharmaLive.com (press release),HUMIRA® is an antibody medication discovered and developed by Knoll AG (a company that Abbott acquired in 2001). The amendment follows the basic agreement

US clears use of Abbott drug for Crohn's disease  -  Feb 27, 2007
Reuters AlertNet,WASHINGTON, Feb 27 (Reuters) - Abbott Laboratories Inc. won US approval on Tuesday to promote its injectable arthritis drug Humira for treating adults with

UPDATE 2-US clears use of Abbott drug for Crohn's disease  -  Feb 27, 2007
ReutersN: Quote, Profile , Research) won US approval on Tuesday to promote its injectable arthritis drug Humira for treating adults with moderate to severe forms

New Crohn's Disease Treatment Approved  -  Feb 28, 2007
Toronto Daily News,The use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's disease has been approved by FDA.

US clears use of Abbott drug for Crohn's disease  -  Feb 27, 2007
Scientific AmericanWASHINGTON (Reuters) - Abbott Laboratories Inc. won US approval to promote its injectable arthritis drug Humira for treating patients with moderate to

UPDATE 1-US clears use of Abbott drug for Crohn's disease  -  Feb 27, 2007
ReutersN: Quote, Profile, Research) won US approval to promote its injectable arthritis drug Humira for treating patients with moderate to severe forms of Crohn's

FDA Approves New Crohn's Disease Treatment  -  Feb 28, 2007
Post ChronicleThe US Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's disease.

FDA approves new Crohn's disease treatment  -  Feb 28, 2007
Earthtimes.org28 The US Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's disease.

FDA approves new Crohn's disease treatment  -  Feb 28, 2007
ImediNews,WASHINGTON (UPI) — The US Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active

FDA approves new Crohn's disease treatment  -  Feb 28, 2007
United Press International28 (UPI) -- The US Food and Drug Administration has approved the use of Humira (adalimumab) to treat adults suffering moderately to severely active Crohn's

New help for rheumatoid arthritis  -  Mar 14, 2007
7Online.com,Three drugs, Remicade, Enbrel and Humira, are the older biologics that can put 80 percent of severe patients into remission. Brian tried Enbrel.

Abbott gets FDA approval to sell arthritis drug for Crohn's disease  -  Feb 28, 2007
Boston Globe,WASHINGTON -- Abbott Laboratories won US approval to market the arthritis drug Humira to treat adults who have the bowel disorder Crohn's disease.

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional